SUBSCRIBE
SUBSCRIBE
BioMidwest

BioCrossroads Makes Plans to Link Indiana’s Drug Development Assets With the Biotech/Pharmaceutical Industry

October 22, 2007 | 
1 min read
--(BUSINESS WIRE)--BioCrossroads: WHAT: News conference to discuss details of a new BioCrossroads initiative WHEN: Thursday, Oct. 25, 2007 at 10:30 a.m. WHERE: Indiana University Emerging Technology Center 351 West 10th St.
Events
MORE ON THIS TOPIC
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Cardiovascular disease
Amgen’s Repatha Cuts Risk of First Heart Attack by 36% in Phase III Trial
November 10, 2025
 · 
4 min read
 · 
Heather McKenzie
Dorval, Quebec, Canada - September 3, 2021: Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada. Novartis is a global healthcare company based in Switzerland.
Immunology and inflammation
Novartis Presents New Data From Potential First Targeted Sjögren’s Treatment
October 29, 2025
 · 
3 min read
 · 
Heather McKenzie
Highway in Phoenix, Arizona leading toward downtown at sunset
Cell and Gene Therapy
Meeting on the Mesa Arrives Amid Mixed Signals for Cell and Gene Therapy
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves
Multiple sclerosis damaged myelin or MS autoimmune disease with healthy nerve with exposed fibre with scarrred cell sheath loss as a 3D illustration.
Multiple sclerosis
Beyond BTK Inhibitors: Next Gen MS Treatments Could Transcend Symptom Management
October 6, 2025
 · 
5 min read
 · 
Ben Hargreaves